Kangrui Bai'ou Bio

Kangrui Bai'ou Bio

Pursuing outstanding performance and trustworthy quality

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Product Center

Kangrui Bai'ou Biotechnology

Technical services support your research efforts. Kangrui Bio-O provides professional technical support services centered around its product platform:

Custom Kit Development Services

Professional custom kit development: on-demand design, validation, and delivery.

Reagent Kit Manufacturing Services

Providing one-stop services for the large-scale production, quality control, and compliant delivery of assay kits.

Reagent Labeling Service

Professional reagent labeling—precise, efficient, stable, and reliable—delivered on demand and tailored to your needs.

Biomarker Testing Services

Professional marker testing services: precise, efficient, reliable data, and rapid turnaround.

The test method development service system is aligned with the product platform.
Enhance the efficiency of experimental workflows and data stability.

Kangrui Bai'ou Biotechnology

About Us

ABOUT US

Wenzhou KanryBio Biotechnology Co., Ltd. (KanryBio) is dedicated to the R&D and manufacturing of bioanalytical technology platforms, having established a comprehensive product portfolio that encompasses instruments, consumables, reagents, and assay kits.
The company has established platforms for electrochemiluminescence, cell sorting, intelligent laboratory automation, and bioanalytical instrumentation, providing stable, scalable technical support for biopharmaceutical R&D and life sciences laboratories.
In addition to its product portfolio, the company also offers custom assay development, antibody labeling, and sample testing services.

15 +

Industry Experience

30 +

Qualification Certification

50 +

Countries and Regions

View more

Complete Product Technical Architecture

Independent R&D and Production Capabilities

Stabilize the supply chain system

ISO 9001 Quality Management System Certification

Blog

Overview of Bioanalytical Methods for Cell Therapy Products

Overview of Bioanalytical Methods for Cell Therapy Products

Cell and gene therapy (CGT) can be broadly classified, based on product format, into ex vivo gene therapy and in vivo gene therapy.

View more
Bioanalytical Strategies for CGT Products: Selected Developments and Validation of qPCR/ddPCR Methodologies

Bioanalytical Strategies for CGT Products: Selected Developments and Validation of qPCR/ddPCR Methodologies

With the rapid development of cell and gene therapy (CGT), dozens of CGT products have now been approved for market launch worldwide.

View more

Pharmaceutical and Biotechnology Industry Watch: Innovative Drugs and Medical Devices Fuel Structured Market Performance; AI in Healthcare Opens New Growth Opportunities

During the third week of February 2025, the pharmaceutical and biotechnology sector continued to exhibit structural divergence. Over the week, the pharmaceutical and biotechnology index rose by 1.88%, outperforming both the CSI 300 Index and the Shanghai Composite Index, ranking ninth in terms of sector performance.

2025-03-01

Pharmaceutical and Biotechnology Industry Watch: AI-Driven Healthcare Applications Accelerate Deployment; Breakthroughs in Payment-Policy for Innovative Drugs

Recently, the pharmaceutical and biotechnology sector has exhibited a pronounced structural market trend, driven by the deep integration of AI technologies with healthcare applications, which is spurring industry upgrades. At the same time, policy support for innovative drugs continues to strengthen, creating multiple favorable factors for the sector.

2025-03-01

With the concerted support of 17 departments, the latest policies for the biopharmaceutical industry in the Jiangsu Pilot Free Trade Zone have been unveiled!

Recently, the “Policy Measures for Coordinated Support from Relevant Provincial Departments for the Open and Innovative Development of the Biopharmaceutical Industry in the China (Jiangsu) Pilot Free Trade Zone” (hereinafter referred to as the “Policy Measures”) were officially released!

2025-03-01